Bendroflumethiazide is a thiazide diuretic indicated for the treatment of hypertension, edema, and urinary tract disorders by promoting sodium and water excretion. Analytical laboratories rely on comprehensive… Read more


![Chemical structure of 3-Benzyl-5-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2725437-59-0-3-Benzyl-5-trifluoromethyl-34-dihydro-2H-benzoe124thiadiazine-7-sulfonamide-11-dioxide.png&w=3840&q=75)









Bendroflumethiazide is a thiazide diuretic indicated for the treatment of hypertension, edema, and urinary tract disorders by promoting sodium and water excretion. Analytical laboratories rely on comprehensive reference standards of the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds to ensure precision in drug development and regulatory compliance. These materials are essential for rigorous impurity profiling, method validation, and the precise identification of potential degradants, including N-nitroso derivatives. Stable isotope labelled versions, in particular, serve as critical internal standards for mass spectrometry-based assays, facilitating accurate quantification and reliable pharmacokinetic studies. By utilizing these specialized reference materials, researchers can maintain consistent quality control and adhere to strict safety standards throughout the pharmaceutical analysis lifecycle.